C
MED icon

Covestor’s Medifast MED Stock Holding History

Covestor’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Sell
15
-68
-82% -$784 ﹤0.01% 2694
2026
Q1 		$1K Buy
83
+24
+41% +$259 ﹤0.01% 2083
2025
Q4 		$1K Buy
59
+30
+103% +$359 ﹤0.01% 2112
2025
Q3 		$0 Sell
29
-36
-55% -$503 ﹤0.01% 2550
2025
Q2 		$1K Sell
65
-2
-3% -$26 ﹤0.01% 2046
2025
Q1 		$1K Sell
67
-27
-29% -$406 ﹤0.01% 2032
2024
Q4 		$2K Sell
94
-564
-86% -$10.5K ﹤0.01% 1902
2024
Q3 		$12K Buy
658
+203
+45% +$3.91K 0.01% 1446
2024
Q2 		$10K Buy
455
+160
+54% +$4.26K 0.01% 1547
2024
Q1 		$12K Buy
295
+155
+111% +$7.51K 0.01% 1457
2023
Q4 		$10K Buy
140
+55
+65% +$3.83K 0.01% 1573
2023
Q3 		$6K Sell
85
-224
-72% -$19.9K ﹤0.01% 1683
2023
Q2 		$29K Buy
309
+308
+30,800% +$27.4K 0.02% 991
2023
Q1 		$0 Sell
1
-12
-92% -$1.33K ﹤0.01% 2350
2022
Q4 		$2K Buy
13
+8
+160% +$932 ﹤0.01% 1789
2022
Q3 		$1K Sell
5
-12
-71% -$1.72K ﹤0.01% 1819
2022
Q2 		$3K Sell
17
-3
-15% -$537 ﹤0.01% 1531
2022
Q1 		$3K Sell
20
-2
-9% -$377 ﹤0.01% 1614
2021
Q4 		$5K Buy
+22
New +$4.55K 0.01% 1319

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Covestor's MED Position: Q2 2026 in Review

Covestor reduced its Medifast (MED) stake by 82% in Q2 2026, selling an estimated $784 and leaving 15 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2694.

Covestor first reported a position in MED in Q4 2021 and has held it in 19 quarters since. The position peaked at $29K in Q2 2023. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Covestor held 15 shares of Medifast worth $0 as of Q2 2026.
  • Covestor sold 68 Medifast shares in Q2 2026, an estimated $784.
  • Medifast made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2694 holding.
  • Covestor first reported a position in Medifast in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Medifast position peaked at $29K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.